Provention Bio Inc (PRVB)

NASDAQ
8.605
+0.185(+2.20%)
  • Volume:
    426,022
  • Day's Range:
    8.430 - 8.660
  • 52 wk Range:
    3.185 - 10.880

PRVB Overview

Prev. Close
8.42
Day's Range
8.43-8.66
Revenue
2.06M
Open
8.46
52 wk Range
3.185-10.88
EPS
-1.54
Volume
426,022
Market Cap
753.33M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,791,785
P/E Ratio
-5.54
Beta
2.36
1-Year Change
102.4%
Shares Outstanding
87,190,667
Next Earnings Date
Feb 23, 2023
What is your sentiment on Provention Bio?
or
Vote to see community's results!

Provention Bio Inc News

Provention Bio Inc Analysis

Provention Bio Inc Company Profile

Provention Bio Inc Company Profile

Provention Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on intercepting and preventing immune-mediated diseases. The Company's product pipeline includes PRV-031 (teplizumab), PRV-3279, PRV-015 (ordesekimab) and PRV-101. Teplizumab is a humanized, anti-CD3 monoclonal antibody (mAb) for the delay of clinical type 1 diabetes (T1D) in at-risk individuals and for patients with newly diagnosed T1D. PRV-3279 is a humanized bispecific scaffold molecule targeting the B-cell surface proteins, CD32B and CD79B, for the treatment of systemic lupus erythematosus (SLE) and for the prevention of immunogenicity of biotherapeutics, such as those used in gene therapy. Ordesekimab is a human anti-interleukin 15 (IL-15) mAb for the treatment of gluten-free diet non-responsive celiac disease (NRCD). PRV-101 is a coxsackievirus B (CVB) vaccine to prevent acute CVB infections and, in those patients at-risk, to prevent the CVB-triggered autoimmune damage to pancreatic beta-cells.

Read More

Analyst Price Target

Average19.714 (+128.519% Upside)
High30.000
Low15.000
Price8.627
No. of Analysts7
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellSellStrong Buy
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Buy
  • earnings? they're in clinical trials.
    0
    • going to pop tomorrow
      0
      • it seems likely
        0
      • why is premarket down? doesn't make sense. I see this as likely being approved as long as the PK data with FDA gets sorted out.
        0
    • https://finance.yahoo.com/news/prvb-shareholder-alert-bronstein-gewirtz-140000371.html
      0
      • interesting info https://www.jdrf.org/blog/2020/06/15/updates-teplizumab-trial-going-believe-results/
        0
        • stock price doesn't GAF
          0
      • Finally some movements
        0
        • So i expected yesterday to have some impact the presentation,now what happened anyone knows? No big changes, still in range of 15
          0
          • Hold till news of fda approval. I see $100 by end of 2021. Happy trading...
            0
        • Waiting for fda, has 60days.
          0
          • Acceptance today! Next milestone mar 22, july 2nd.
            0
        • November 18 ,2020 will go big They present good results
          0
          • Now buy?
            0
            • Fasktrak meeting in Dec2019
              0